15 September 2010 September 14, 2010 — The US Food and Drug Administration (FDA) will consider revising the labels of the osteoporosis drugs bisphosphonates in light of a new report stating that long-term bisphosphonate use may increase the risk for unusual femur fracture, the agency announced ...

14 July 2010  In the last 20 years, a vast amount of scientific knowledge has been gathered about how insulin-producing cells develop, function and survive in the normal human body and how they become compromised and destroyed in diabetic patients. In recent years, interest in diabetes has inten...

6 July 2010    By Nor Azmi Kamaruddin* National University of Malaysia Kuala Lumpur The introduction of thiazolidinedione (TZD) in the late 1990s heralded a new landmark in the management of diabetes mellitus. It was the first among the anti-diabetic agents that specifically addressed the issue...

5 July 2010  The Endocrine Society (USA) issued a scientific statement titled “Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement” that was published in the July 2010 issue of the Journal of Clinical Endocrinology & Metabolism (JCEM). This statement evaluates benefits an...

15 March 2010  FDA puts black box warning on Plavix, says certain patients can’t process blood thinner   WASHINGTON (AP) — The Food and Drug Administration is adding its strongest warning to the label for Plavix, cautioning that some patients do not respond to the blockbuster blood thinner.  ...

17 February 2010  Statin therapy increases the risk of diabetes and patients taking the drugs should have their blood glucose monitored on a regular basis, according to articles published in the Lancet today. A meta-analysis of 13 statin trials with more than 90,000 patients found that use of th...